ConductScience.org, home

Paper · 36804602

Pancreatic Cancer: Changing Epidemiology and New Approaches to Risk Assessment, Early Detection, and Prevention.

Stoffel EM and 2 others. Gastroenterology, 2023. Cited by 462 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Pancreatic Cancer: Changing Epidemiology and New Approaches to Risk Assessment, Early Detection, and Prevention. Papers, record 36804602. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36804602

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pancreatic Cancer: Changing Epidemiology and New Approaches to Risk Assessment, Early Detection, and Prevention.
PubMed
Journal
Gastroenterology
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
462
iCite
Relative citation ratio, by iCite
48.4
iCite
Revised in PubMed
2024-01-02
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stoffel EMElena M
2Brand RERandall E
3Goggins MMichael

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Early Detection of CancerMajor topic
Pancreatic NeoplasmsMajor topic
Humans
Risk Assessment
Pancreas
Risk Factors

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 CA176828NCI NIH HHSUnited StatesR01CA176828PubMed and NIHNIH RePORTER
U01 CA210170NCI NIH HHSUnited StatesU01CA210170PubMed and NIHNIH RePORTER

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT06638866AI-powered Early Detection for Pancreatic Cancer Via Non-contrast CT in Opportunistic Screening CohortBackground

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References118

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129,485,131ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts.Am J Gastroenterol2018https://conductscience.org/library/papers/29485131PubMed
230,946,242Cost-effectiveness of Pancreatic Cancer Surveillance in High-Risk Individuals: An Economic Analysis.Pancreas2019https://conductscience.org/library/papers/30946242PubMed
335,166,713Detection of Early-Stage Pancreatic Ductal Adenocarcinoma From Blood Samples: Results of a Multiplex Biomarker Signature Validation Study.Clin Transl Gastroenterol2022https://conductscience.org/library/papers/35166713PubMed
436,316,508Racial Disparity in Pathologic Response following Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: A Multi-Institutional Analysis from the Central Pancreatic Consortium.Ann Surg Oncol2023https://conductscience.org/library/papers/36316508PubMed
532,675,550Timing But Not Patterns of Recurrence Is Different Between Node-negative and Node-positive Resected Pancreatic Cancer.Ann Surg2020https://conductscience.org/library/papers/32675550PubMed
635,333,778Imaging of the Pancreas in New-Onset Diabetes: A Prospective Pilot Study.Clin Transl Gastroenterol2022https://conductscience.org/library/papers/35333778PubMed
730,721,664Early Detection of Pancreatic Cancer: Opportunities and Challenges.Gastroenterology2019https://conductscience.org/library/papers/30721664PubMed
834,648,951Serum Carboxypeptidase Activity and Genotype-Stratified CA19-9 to Detect Early-Stage Pancreatic Cancer.Clin Gastroenterol Hepatol2022https://conductscience.org/library/papers/34648951PubMed
932,213,015The diagnostic work-up and outcomes of 'presumed' idiopathic acute pancreatitis: A post-hoc analysis of a multicentre observational cohort.United European Gastroenterol J2020https://conductscience.org/library/papers/32213015PubMed
1036,157,927International patterns in incidence and mortality trends of pancreatic cancer in the last three decades: A joinpoint regression analysis.World J Gastroenterol2022https://conductscience.org/library/papers/36157927PubMed

Cited by343

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 462 citations.

PMIDTitleJournalYearIn PapersSource
42,967,213The Role and Mechanism of NCAPD2 In Regulating the P53 Signaling Pathway to Mediate the Proliferation and Invasion of Pancreatic Cancer Cells.Rep Biochem Mol Biol2025https://conductscience.org/library/papers/42967213PubMed
42,935,641Global and registry-based patterns of pancreatic cancer: GLOBOCAN 2020, CI5plus trends (2000-2017), and demographic projections to 2040.Front Oncol2026https://conductscience.org/library/papers/42935641PubMed
42,928,513NCLX Inhibition plus Ca2+ Delivery Potentiates Electroporation and Antitumor Immunity in Pancreatic Ductal Adenocarcinoma.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42928513PubMed
42,910,299HMGA2 Stabilizes hnRNPK to Drive YAP-Dependent Liver Metastasis in Pancreatic Cancer.Int J Biol Sci2026https://conductscience.org/library/papers/42910299PubMed
42,897,094Diabetes Among Finnish Pancreatic Cancer Patients: Prevalence, Time Interval Between Diabetes and Cancer Diagnosis, and Overall Survival.Cancer Med2026https://conductscience.org/library/papers/42897094PubMed
42,885,518Optimisation and mechanistic characterization of a selective benzoxazine-based MAP4K4 inhibitor in pancreatic cancer cells.J Enzyme Inhib Med Chem2026https://conductscience.org/library/papers/42885518PubMed
42,885,341Skeletal Muscle Index, Tumor and Systemic Immunity, and Survival in Advanced Pancreatic Ductal Adenocarcinoma.Cancer Med2026https://conductscience.org/library/papers/42885341PubMed
42,877,528Strategy for early diagnosis of pancreatic cancer.Front Gastroenterol (Lausanne)2026https://conductscience.org/library/papers/42877528PubMed
42,866,755Borderline resectable pancreatic ductal adenocarcinoma: a narrative review.Ann Med Surg (Lond)2026https://conductscience.org/library/papers/42866755PubMed
42,856,819Development of a predictive model for pancreatic cancer integrating serum metabolomics and polygenic risk score.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42856819PubMed

1 to 10 of 343

See all 343 cited by

Genes23

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36804602

GET https://conductscience.org/api/papers/v1/36804602/references?page=2